Wei Luo
Peking Union Medical College
8 Papers
16 Citations
Wei Luo is an academic researcher from Peking Union Medical College. The author has contributed to research in topics: Breast cancer & Neoadjuvant therapy. The author has an hindex of 3, co-authored 7 publications.
Chat about Author
Papers
Comparison of histopathologic changes and expression of biomarkers in breast carcinoma before and after neoadjuvant chemotherapy
Shan Zheng,Bo-lin Zhang,Ting Xiao,Shuangmei Zou,Liyan Xue,Wei Luo,Lei Guo,Xiuyun Liu,Ning Lu +8 more
TL;DR: Analysis of core needle biopsy can provide important information to predict the pathologic responses to the NAC, and it is necessary to examine the histologic type, grade and the expression of ER, PR and HER2 after NAC once more.
10
•Journal Article
Expression of annexin I in different histological types of carcinomas
TL;DR: Investigation of the expression of annexin I in esophageal squamous cell carcinoma (SCC) and carcinomas of other histological types found that it was decreased, and Annexin I expression is quite different among different types of carcinomas, and is correlated with histopathological type and differentiation grade.
10
Expression of fascin and cytokeratin 14 in esophageal squamous cell carcinoma
Liyan Xue,Yongmei Song,Tong Tong,Wei Luo,Lijia Dong,Shuang-mei Zou,Shan Zheng,Rui Bi,Qimin Zhan,Ning Lu +9 more
TL;DR: Finn and CK14 may play important roles in the carcinogenesis and progression of ESCC and combination of fascin and CK 14 would be valuable markers in diagnosis of ES CC.
3
Differences between clinical response and pathologic response of breast cancer after neoadjuvant chemotherapy
Shan Zheng,Bo-lin Zhang,Ren-Zhi Zhang,Jianliang Yang,Shuangmei Zou,Liyan Xue,Wei Luo,Yanling Yuan,Ning Lu +8 more
TL;DR: The pathologic basis of the difference between clinical response and pathologic response of breast carcinoma after neoadjuvant chemotherapy is investigated to investigate whether the clinical response may be related to the pathological response.
2
[Efficacy and initial clinical evaluation of optical genome mapping in the diagnosis of structural variations].
Na Hao,J. Zhou,M. M. Li,Wei Luo,H. Zhang,Qing-wei Qi,Y. Jiang,X Y Zhou,K. Yang,H. Chen,Hong Pan,J. Zhu,Juntao Liu +12 more
- 06 May 2022
TL;DR: Results demonstrated that optical genome mapping as a new technology can not only detect unbalanced rearrangements such as copy number variants as well as balanced translocations and inversions, but more importantly, it can refine breakpoints and orientation of duplicated segments or insertions.
2